JB

Jyothi Bashaboina

Active Director Director DIN 09854369
DIN 09854369 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyothi Bashaboina

Data last updated:

Jyothi Bashaboina is a Director at Dr.Cetlix Pharma Private Limited (since 2023). The company operates in Chemicals.

DIN 09854369
Primary Designation Director
Industry Chemicals
First Appointment 06 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr.Cetlix Pharma Private Limited U24239TG2023PTC170178
Director06 Jan 20232023Active

Board colleagues of Jyothi Bashaboina

NameDINCompanyDesignation
Dolu Ramya Soujanya09854367Dr.Cetlix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr.Cetlix Pharma Private Limited
Premium access

Shareholding and investment profile for Jyothi Bashaboina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyothi Bashaboina

Jyothi Bashaboina currently holds 1 directorship: Dr.Cetlix Pharma Private Limited (Director, since 06 Jan 2023).

Jyothi Bashaboina was first appointed on 06 Jan 2023 as Director at Dr.Cetlix Pharma Private Limited.

The current boards of Jyothi Bashaboina's companies include Dolu Ramya Soujanya (Dr.Cetlix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available